Pune-based Indian medical firm The Serum Institute of India (SII) announced Monday that their swine flu vaccine 'Fluvac' would be available in the market by April-May 2010.
SII started the Phases two and three of the clinical human trials of the nasal form of vaccine Monday on 330 participants at different locations around the country.
According to Dr Prasad Kulkarni, the director of clinical trials at the institute, SII got the green signal from the Drug Controller General of India (DCGI) on March 5 to carry out advanced safety tests on the swine flu vaccine.
Clinical trials
As per reports, 330 people in three groups--paediatric, adult and elderly (9-19 years, 20-48 years and 48 and above)--will be put under the trial.